A patient self-assessment software combining compliance protocols to improve prescriber confidence, reduce liability, and improve patient outcomes.
A patient self-assessment software combining compliance protocols to improve prescriber confidence, reduce liability, and improve patient outcomes.
批准号:
10226096
负责人:
ABRAHAM G HARTZEMA
金额:
$93.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2023-07-31
关键词:
Activities of Daily LivingAlternative TherapiesBenefits and RisksCaringChronicClinicClinicalComputer softwareComputerized Medical RecordContinuity of Patient CareControl GroupsDangerousnessDataDependenceDevicesDocumentationElectronic Health RecordEnvironmentEpidemicEvaluationExposure toFentanylFrightFutureGoalsHealth TechnologyInternetInterventionKnowledgeLawsLegalMeasuresMedicalMonitorMorphineOnline SystemsOpioidOutcomeOutcomes ResearchOverdosePainPain managementPatient CarePatient riskPatient-Focused OutcomesPatientsPharmaceutical PreparationsPharmacologic SubstancePhasePhysical FunctionPhysiciansPlayPoliciesPrimary Health CareProbabilityProtocol ComplianceProtocols documentationProviderReportingResearchResearch PersonnelRiskRisk FactorsRoleSelf AssessmentStandardizationTechnical ExpertiseTimeTrainingVisitWithdrawaladdictioncare systemscommercializationdashboarddesigndigital healthexperiencehelp-seeking behaviorhigh riskimprovedmilligrammortalitynon-cancer painnovelopioid epidemicopioid misuseopioid overdoseopioid therapyoverdose deathpatient populationpatient safetyprescription opioidprogramspublic health relevancesoftware developmentsubstance misusesynthetic opioidtoolwillingness
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
The current overdose epidemic is being fueled by widespread, non-medical use of opioids
prescribed by mostly well-meaning physicians with inadequate training on how to properly
initiate, monitor and discontinue opioid therapy. Many patients being initiated on chronic opioid
therapy have factors putting them at higher risk for substance misuse and possible future
overdose, however the typical primary care visit for a new patient is too short for a thorough evaluation.
This puts patients at risk by perpetuating a substandard level of care, and puts prescribers at risk by lacking
substantiated documentation to support the legal standard “legitimate medical purpose”. Most current measures
aimed at solving the opioid epidemic have not considered the biggest obstacle to appropriate patient care and
good medicolegal documentation, which is time. To complicate the matter, many physicians are simply refusing
to prescribe opioids for fear of criminal, civil or regulatory intervention. This is compounding the issue by
inundating clinics that do prescribe opioids with new, unverified patients that are often almost out of medication
or already in withdrawal. This common scenario is contributing to the steady rise of fentanyl and other synthetic
opioid related overdose deaths by pushing patients with pain, dependence and addiction to seek help through
illegal means. The Care Continuity Program (CCP), a product of Sure Med Compliance, is a novel, online patient
self-assessment used by prescribers of opioids to better identify patient risk factors and therapy benefit. This tool
is completed by the patient, outside of the office, using an internet enabled device and follows a compliance
driven protocol developed by analyzing case law against physicians in mis-prescribing opioid cases. Results, in
the form of a date and time stamped legal report, are instantly transmitted to the prescriber’s electronic health
records, mitigating the prescriber’s civil and criminal risk. A brief of findings is displayed within the software
through a dashboard and on the summary page of the report. This software offering includes a mobile and
standard web-based application. The objective of the proposed research is to validate the protocols and delivery
system of the CCP by measuring patient outcomes, prescriber confidence, and completeness of documentation
in the patient chart in primary care and pain management settings, pre and post implementation of the CCP.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/s40264-022-01267-z
发表时间:
2023-03
期刊:
DRUG SAFETY
影响因子:
4.2
作者:
[Wang, Shuang, Meador, Kimford J., Pawasauskas, Jayne, Lewkowitz, Adam K., Ward, Kristina E., Brothers, Todd N., Hartzema, Abraham, Quilliam, Brian J., Wen, Xuerong]
通讯作者:
Wen, Xuerong
A patient self-assessment software combining compliance protocols to improve prescriber confidence, reduce liability, and improve patient outcomes.
-
批准号:10013399
-
项目类别:
-
资助金额:$72.23万
-
财政年份:2020
-
负责人:ABRAHAM G HARTZEMA
-
依托单位:
HIT for Medication Safety in Critical Access Hospitals
-
批准号:6890734
-
项目类别:
-
资助金额:$14.78万
-
财政年份:2004
-
负责人:ABRAHAM G HARTZEMA
-
依托单位:
海外基金